← Leaderboards
Dong Wang
University Of Nebraska Medical Center
$7,094,561
Attributed
$7,094,561
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $931.4K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,094,561 · 7
By mechanism
R01$7,093,936 · 5
P41$625 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Methacrylamide”
- Jindrich N. Kopecek · Utah State Higher Education System--University Of Utah$12,409,638
- Carmem S. Pfeifer · Oregon Health & Science University$9,780,734
- Steven Reyburn Goldring · Beth Israel Deaconess Medical Center$1,933,011
- Daniel Alge · Texas Engineering Experiment Station$1,605,517
- Jack L. Ferracane · Oregon Health And Science University$1,565,171
- Francis C Szoka · University Of California San Francisco$1,438,205
Research focus
MethacrylamideTissuesIn VivoSafetyBiodistributionInflammatoryDrug KineticsDesignCellsMouse ModelIn VitroInflammationChronicGlucocorticoidsCopolymerMolecular WeightSiteLabelTreatment EfficacyPharmaceutical PreparationsPolymersBaseKineticsProdrugs
Grant awards (21)
Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain$430,589
R01 · FY2025 · AR · contact PI
Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union$427,763
R01 · FY2025 · AR · contact PI
Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain$464,079
R01 · FY2024 · AR · contact PI
Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union$427,763
R01 · FY2024 · AR · contact PI
Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain$478,432
R01 · FY2023 · AR · contact PI
Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union$453,017
R01 · FY2023 · AR · contact PI
Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain$478,432
R01 · FY2022 · AR · contact PI
Nanomedicine Development for Systemic Lupus Erythematosus$376,250
R01 · FY2020 · AI · contact PI
Nanomedicine Development for Systemic Lupus Erythematosus$376,250
R01 · FY2019 · AI · contact PI
Nanomedicine Development for Systemic Lupus Erythematosus$376,250
R01 · FY2018 · AI · contact PI
Nanomedicine Development for Systemic Lupus Erythematosus$376,250
R01 · FY2017 · AI · contact PI
Nanomedicine Development for Systemic Lupus Erythematosus$376,250
R01 · FY2016 · AI · contact PI
Early Detection and Intervention of Orthopedic Implant Loosening using Polymer Th$342,125
R01 · FY2016 · AR · contact PI
Early Detection and Intervention of Orthopedic Implant Loosening using Polymer Th$342,125
R01 · FY2015 · AR · contact PI
Early Detection and Intervention of Orthopedic Implant Loosening using Polymer Th$342,125
R01 · FY2014 · AR · contact PI
Early Detection and Intervention of Orthopedic Implant Loosening using Polymer Th$352,857
R01 · FY2013 · AR · contact PI
STRUCTURE DETERMINATION OF PROTEIN COMPLEXES INVOLVED IN DNA LESION PROCESSING$279
P41 · FY2011 · RR · contact PI
STRUCTURE DETERMINATION OF PROTEIN COMPLEXES INVOLVED IN DNA LESION PROCESSING$346
P41 · FY2010 · RR · contact PI
Macromolecular Therapy for Improved Treatment of Rheumatoid Arthritis$222,943
R01 · FY2009 · AR · contact PI
Macromolecular Therapy for Improved Treatment of Rheumatoid Arthritis$222,943
R01 · FY2008 · AR · contact PI
Macromolecular Therapy for Improved Treatment of Rheumatoid Arthritis$227,493
R01 · FY2007 · AR · contact PI